116 filings
Page 5 of 6
POS EX
ewsn9s 2wiv
5 Mar 21
Additional exhibits for listing
4:01pm
EFFECT
fknz10s70xywdig9
5 Mar 21
Notice of effectiveness
12:15am
CORRESP
eneqnx7q4
2 Mar 21
Correspondence with SEC
12:00am
CORRESP
tc9i5wns5mh7g3t8
2 Mar 21
Correspondence with SEC
12:00am
UPLOAD
0sdsfh25mf7n
1 Mar 21
Letter from SEC
12:00am
DRS
xskham kp8
22 Feb 21
Draft registration statement
12:00am
10-K
up0ku
16 Feb 21
Annual report
4:11pm
8-K
hfr4z747fm0c1
16 Feb 21
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update
4:05pm
S-8
fustqkfepu2
16 Feb 21
Registration of securities for employees
12:00am
8-K
qxriksv40nqhx7spad
7 Dec 20
Regulation FD Disclosure
6:06am
8-K
z7ijnt3g
26 Oct 20
Nurix Therapeutics Announces Appointment of Robert Tjian as Chairman of Scientific Advisory Board and His Resignation from the Board of Directors
4:05pm
8-K
0gkfxcv9xlpd
14 Oct 20
Nurix Therapeutics Reports Third Quarter Fiscal 2020 Financial Results and Provides a Corporate Update
4:05pm
10-Q
o8seqbcq1uu5g 7pw11
14 Oct 20
Quarterly report
4:02pm
8-K
tag e12pwq8usc
14 Oct 20
Regulation FD Disclosure
2:01pm
424B4
fs85defv22abvnn1tm5
24 Jul 20
Prospectus supplement with pricing info
4:06pm
EFFECT
og81r
24 Jul 20
Notice of effectiveness
12:15am
S-8
ipw72
23 Jul 20
Registration of securities for employees
9:28pm
CERT
0ouso1nb
23 Jul 20
Certification of approval for exchange listing
9:45am